LEN
57
2
D
58
-2
AKAM
64
2
O
50
19
BIIB
25
-12
FLS
59
3
IFF
62
5
NEE
63
16
WU
22
10
AN
52
2
MRO
43
-12
KMX
49
2
XYL
52
-2
MTB
61
-3
MET
64
11
MO
35
2
V
62
6
PYPL
47
4
NKE
43
-3
CMG
64
13
LEN
57
2
D
58
-2
AKAM
64
2
O
50
19
BIIB
25
-12
FLS
59
3
IFF
62
5
NEE
63
16
WU
22
10
AN
52
2
MRO
43
-12
KMX
49
2
XYL
52
-2
MTB
61
-3
MET
64
11
MO
35
2
V
62
6
PYPL
47
4
NKE
43
-3
CMG
64
13
Financhill
Back

iShares Global Energy ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
42

IXC
iShares Global Energy ETF

Last Price:
41.14
Seasonality Move:
1.3%
Sell
22

APLS
Apellis Pharmaceuticals

Last Price:
32.71
Seasonality Move:
18.8%
Sell
42
iShares Global Energy ETF (IXC) is a Sell

Is iShares Global Energy ETF a Buy, Sell or Hold?

  • The current iShares Global Energy ETF [IXC] share price is $41.11. The Score for IXC is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • IXC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.72. The Score for APLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IXC Stock Price Chart

What is iShares Global Energy ETF's stock price today?

  • The iShares Global Energy ETF share price today is $41.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IXC is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

IXC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 55.9 Buy
Chaikin Money Flow: 143772 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.72 - 41.68) Buy
Bollinger Bands (100): (40.4 - 42.72) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.09 Sell
Relative Strength Index (14 RSI): 34.53 Sell
Chaikin Money Flow: 2311416 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.9 - 40.1) Sell
Bollinger Bands (100): (36.41 - 42.27) Sell

IXC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.22 Buy
20-day SMA: 40.53 Buy
50-day SMA: 41.01 Buy
200-day SMA: 41.02 Buy
8-day EMA: 40.45 Buy
20-day EMA: 40.48 Buy
50-day EMA: 40.88 Buy
200-day EMA: 40.96 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.48 Sell
20-day SMA: 37.67 Sell
50-day SMA: 37.75 Sell
200-day SMA: 49.84 Sell
8-day EMA: 35.24 Sell
20-day EMA: 36.78 Sell
50-day EMA: 38.03 Sell
200-day EMA: 45.57 Sell

iShares Global Energy ETF Earnings Growth & IXC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.32 per share.

iShares Global Energy ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):